Impax Laboratories Reacts To SEC Suspension

Law360, New York (January 10, 2007, 12:00 AM EST) -- Impax Laboratories Inc. has countered a recent order by the U.S. Securities and Exchange Commission to suspend its trading by saying that the suspension is not necessary to protect investors.

At the end of December, the SEC issued an order for an administrative proceeding to see whether the registration of Impax’ securities should be suspended or revoked since Impax hadn’t filed a financial report since September 2004. It also suspended trading of the company’s shares from December 29, 2006 to January 16, 2007, citing the failure...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.